Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery
- PMID: 15804151
- PMCID: PMC4680807
Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery
Abstract
Acute preoperative plateletpheresis (APP), cell salvage (CS) technique, and the use of aprotinin have been individually reported to be effective in reducing blood loss and blood component transfusion while improving hematological profiles in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). In this prospective randomized clinical study, the efficacy of these combined approaches on reducing blood loss and transfusion requirements was evaluated. Seventy patients undergoing primary coronary artery bypass grafting (CABG) were randomly divided into four groups: a control group (group I, n = 10) did not receive any of the previously mentioned approaches. An APP and CS group (group II, n = 20) experienced APP in which preoperative platelet-rich plasma was collected and reinfused after reversal of heparin, along with the cell salvage technique throughout surgery. The third group (group III, n = 22) received aprotinin in which 5,000,000 KIU Trasylol was applied during surgery, and a combination group (group IV, n = 18) was treated with all three approaches, i.e., APP, CS, and aprotinin. Compared with group I (896+/-278 mL), the postoperative total blood loss was significantly reduced in groups II, III, and IV (468+/-136, 388+/-122, 202+/-81 mL, respectively, p < 0.05). The requirements of packed red blood cells in the three approached groups (153+/-63, 105+/-178, 0+/-0 mL, respectively) also were reduced when compared with group I (343+/-118 mL, p < 0.05). In group I, six patients (6/10) received fresh-frozen plasma and three patients (3/10) received platelet transfusion, whereas no patients in the other three groups required fresh-frozen plasma and platelet. In conclusion, both plateletpheresis concomitant with cell salvage and aprotinin contribute to the improvement of postoperative hemostasis, and the combination of these two approaches could minimize postoperative blood loss and requirement.
Conflict of interest statement
The senior author has stated that authors have reported no material, financial or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper.
Figures
References
-
- Chavez AM, Cosgrove DM.. Blood conservation. Semin Thorac Cardiovasc Surg. 1990;2:358–63. - PubMed
-
- Breyer RH, Engelman RM, Rousou JA, Lemeshow SA.. A comparison of cell saver versus ultrafilter during coronary artery bypass operations. J Thorac Cardiovasc Surg. 1985;90:736–40. - PubMed
-
- Hall RI, Schweiger IM, Finlayson DC.. The benefit of the Hemonetics cell saver apparatus during cardiac surgery. Can J Anaesth. 1990;37:618–23. - PubMed
-
- Boldt J, Kling D, Zickmann B, Jacobi M, Dapper F, Hempelmann G.. Acute preoperative plasmapheresis and established blood conservation techniques. Ann Thorac Surg. 1990;50:62–8. - PubMed
-
- Gravlee GP.. Autologous platelet-rich plasma in cardiac surgery: aesthetics versus virtue. J Cardiothorac Vasc Anesth. 1993;7:1–3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical